A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer


YALCIN S. , Uslu R. , DANE F., YILMAZ U., ZENGIN N., BUYUKUNAL E., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.29, 2011 (SCI İndekslerine Giren Dergi) identifier